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1102-50 Coronary Arteries Partially Recovered Endothelium-
Dependent Function Three Months After Endovascular 
Irradiation
Keith A. Robinson, Jinsheng Li, Bunken Ebato, Jianhua Cui, Nicolas A. F. Chronos, 
American Cardiovascular Research Institute, Norcross, GA
Background: Radiation therapy inhibits restenosis after coronary intervention but
appears to exert long-term inhibition of endothelial recovery. Also, to avoid geographic
miss, normal artery adjacent to the intervention site is irradiated during brachytherapy
procedures. The effect of vascular brachytherapy on normal coronaries, mimicking such
segments, has not been studied. We investigated ex vivo vasomotor function at long-term
follow-up after endovascular brachytherapy, and correlated functional responses to mor-
phology and eNOS expression. Methods: Vascular responses of pig coronaries to endot-
helium-dependent and independent vasoactive agents 3 mo after active irradiation (RAD;
n=12; 20Gy β), sham (S; n=8; catheter with inactive wire), and in native controls (C; n=8)
were examined. Endothelial morphology was studied by scanning electron microscopy
(SEM), and eNOS immunohistochemistry was also performed. Results: Relaxation to
maximal dose A23187 (3µM) was decreased in RAD (31.2±4.7% vs. 87.3±2.7% in S and
85.7±4.4% in C; P<0.01). Relaxation to maximal dose substance P (0.1nM) was also
less for RAD (32.0±4.6% vs. 47.3±3.1% in S and 70.2±5.1% in C; P<0.05). For RAD,
contraction to PGF2α with L-NAME was similar to PGF2α only (2.42±0.45 vs. 2.52±0.42;
NS), but was increased in S and C. Contraction to KCl was decreased in RAD. Endothe-
lium-independent relaxation to sodium nitroprusside was increased in RAD compared to
S and C. There was confluent endothelium in irradiated vessels by SEM. Immunohis-
tochemical staining for eNOS showed similar pattern and intensity for RAD and S. Con-
clusions: Comparison to previous results (not shown) at 1 mo post-irradiation,
endothelium-dependent relaxations were partially (≈40-50%) recovered at 3 mo. Endot-
helial morphology and immunohistochemical staining revealed that structural recovery
was complete, and no difference in eNOS expression assessed by immunostaining could
be observed. These results indicate that functional endothelial recovery of irradiated nor-
mal coronaries was still incomplete at 3 mo; this may have important implications in ther-
apeutic planning for clinical brachytherapy patients.
1102-51 Long-Term Efficacy of Intracoronary Beta-Radiation for 
the Treatment of In-Stent Restenosis: An Angiographic 
and Intravascular Ultrasound Analysis of the Late 
Catch-Up Phenomenon
Juan S. Muñoz, F. Feres, A. Abizaid, R. Staico, L. Mattos, G. Maldonado, M. Centemero, 
L. Tanajura, I. Pinto, A. S. Abizaid, A. Chaves, A. Sousa, J. E. Sousa, Institute Dante 
Pazzanese of Cardiology, Sao Paulo, Brazil
Background: Intracoronary Beta-Radiation Therapy (BRT) has been shown to inhibit
intra-stent intimal hyperplasia (IH) at 6-month follow-up (FUP) in the treatment of in-stent
restenosis (ISR) lesions. However, there are few data about in-stent lumen deterioration
within longer FUP after BRT. Purpose: To compare the clinical, angiographic and intra-
vascular ultrasound (IVUS) outcomes of patients (pts) with ISR treated with balloon
angioplasty followed by BRT at 6 and 12-month FUP. Methods: Forty consecutive pts
with ISR were treated with BRT (Novoste, Beta-Cath). Clinical, angiographic and IVUS
analysis was performed in 25 pts (63%) at 6 and 12-month FUP. Results: Eighty percent
(20/25) and 64% (16/25) of pts were free of major adverse cardiac events at 6 and 12-
month FUP, respectively; (p=0.3). Significant in-stent lumen loss (0.24±0.44mm, p=0.04)
and IH growth (+11.2±0.48 mm3, p=0.03) was observed between 6 and 12-month FUP.
Angiographic and IVUS analysis are shown below.
†p<0.05 vs. 6-month. MLD= Minimal lumen diameter. %DS= Stenosis diameter percent.
Conclusions: Significant luminal deterioration (late catch-up) was observed within the
stents between 6 and 12 months after BRT, due an important late progression of in-stent
IH, in the treatment of ISR lesions.
1102-52 A Therapeutic Adenoviral-Eluting Stent Suppresses 
Neointimal Formation via Induction of Apoptosis
Thomas W. Johnson, Yin Xiong Wu, Christian Herdeg, Andreas Baumbach, Andrew 
Newby, Karl Karsch, Martin Oberhoff, Bristol Heart Institute, University of Bristol, Bristol, 
United Kingdom, University of Tubingen, Tubingen, Germany
Background: Effective stent-based delivery of a first-generation adenoviral vector (AdV),
over-expressing tissue inhibitor of metalloproteinase 3 (TIMP3), has already been dem-
onstrated in-vivo and importantly, resulted in a 40% reduction in neointimal proliferation
at 28days. The aim of this work was to elucidate the mechanism for this profound effect
and assess the inflammatory response to this novel interventional therapy.
Method: Matrix HI phosphorylocholine-coated (PC) stents (Abbott, U.S.A.), coated with
TIMP3 AdV or a Control, lacZ (reporter gene), AdV were deployed in porcine coronary
arteries for 7days prior to explanting, RNA extraction, fixation and histological preparation
(n=5). Human TIMP3 production was assessed with immunocytochemical (ICC) tech-
niques and RT-PCR. Apoptosis was assessed by ICC staining for PARP, in addition, α-
actin staining was used to confirm that smooth muscle cells were the predominant target.
Evaluation of the inflammatory response surrounding each stent strut was evaluated
using an ICC stain for macrophages, MAC387. The inflammation score was defined as
the proportion of neointimal cells staining positive around each strut (0=No cells;
1=<33%; 2=33-66%; 3=>66%).
Results: Despite homogeneity between porcine & human TIMP3 mRNA, TIMP3 over-
expression was evident in stented coronary tissue, transfected with TIMP3 AdV, when
compared to control (data not shown), this was confirmed with TIMP3 ICC. The
increased level of TIMP3 corresponded with a significantly increased rate of apoptosis,
41.0±15.6% vs 8.9±8.1% in control (p=0.004). Crucially, the increase in apoptosis was
not associated with a reduction in cell density, 32.6±1.8% vs. 33.6±4.0% in control
(p=0.62). Inflammation scores did not differ between the groups: TIMP3 1.5±0.6 vs. Con-
trol 1.4±0.4, p=0.69.
Discussion: Apoptosis has been confirmed as a major contributor to TIMP3’s inhibitory
effect on neointimal proliferation, following intra-coronary stent deployment. Importantly,
this does not effect cell density or induce significant inflammation at 7days, thus main-
taining normal vessel architecture.
1102-53 CX3CR1 Gene Disruption Is Not Associated With 
Decreased Neointima Formation After Carotid Wire 
Injury in Apolipoprotein-E Deficient Mice
Joshua J. Fischer, Yuquing Huo, Daniel K. Bennett, Melissa Bevard, Christopher J. Davis, 
Klaus Ley, Ian J. Sarembock, University of Virginia Health System, Charlottesville, VA
Background:The fractalkine receptor (CX3CR1) is found on leukocytes and binds to
endothelial cells expressing fractalkine(CX3CL1), facilitating leukocyte firm adhesion and
transmigration, steps thought to be important in the development of atherosclerosis.
Recently published studies have shown that CX3CR1-/-/apoE-/- mice have decreased
spontaneous atherosclerosis when compared to apoE-/- control mice. Accordingly, we
hypothesized that CX3CR1-/-/apoE-/- mice would have diminished neointimal growth at
28 days after carotid wire denudation injury.
Methods: CX3CR1-/-/apoE-/- mice (n=13) or apoE-/- mice (n=8) were fed a Western diet
for one week prior to wire denudation of the left common carotid artery, and continued on
the atherogenic diet for four additional weeks. At 28 days after injury, cholesterol levels
were measured, and the carotid arteries were harvested for histomorphometric analysis.
Results are reported as mean + SEM.
Results: There was no difference between the two groups in total cholesterol (1284 + 57
mg/dL CX3CR1-/-/apoE-/- vs. 1231 + 49 mg/dL apoE-/-, p=NS) or LDL cholesterol (1138 +
52 mg/dL CX3CR1-/-/apoE-/- vs. 1101 + 46 mg/dL apoE-/-, p=NS). CX3CR1-/-/apoE-/-
mice did not have diminished neointima, and in fact there was a trend towards a larger
neointima at 28 days in the CX3CR1-/-/apoE-/- mice versus control apoE-/- mice (77,000 +
15,000 µm2 vs. 44,000 + 11,000 µm2, p=0.14).
Conclusion: CX3CR1-/-apoE-/- mice do not have a decrease in neointimal growth after
carotid wire denudation injury. In fact, there was a trend towards a larger neointima. The
protective effect of CX3CR1 gene disruption reported in spontaneous atherosclerosis
studies is not seen in this model of vascular injury on an atherogenic background.
Peptide treated mice (n = 8) Saline treated mice (n = 8)
Luminal area(mm2) 0.070 ± 0.030 0.048 ± 0.029
Intimal area(mm2) 0.009 ± 0.006 0.022 ± 0.012*
Medial area(mm2) 0.024 ± 0.007 0.029 ± 0.009
IEL(mm2) 0.080 ± 0.034 0.071 ± 0.035
EEL(mm2) 0.104 ± 0.036 0.099 ± 0.043
I/M 0.374 ± 0.206 0.795 ± 0.368*
Post (n=25) 6-month (n=25) 12-month (n=25)
Reference Diameter (mm) 2.72±0.36 2.69±0.36 2.68±0.33
MLD in-stent (mm) 1.98±0.26 1.83±0.37 1.64±0.55†
MLD in-segment (mm) 1.95±0.26† 1.53±0.40 1.47±0.43
%DS in-stent 24.4±8.2 27.5±7.8 46.8±4.8†
%DS in-segment 21.6±6.7† 33.1±6.2 39.6±5.8
Late loss in-stent (mm) - 0.16±0.42 0.34±0.46†
Late loss in-segment (mm) - 0.35±0.45 0.48±0.32
Angiographic restenosis - 4 (16%) 8(32%)
In-Stent IH(mm3) 40.4±16.3 47.1±20.0 58.2±13.3†
% Volume Obstruction 26.8±7.2 30.5±8.0 38.7±7.8†
